What is Recursion Pharmaceuticals, Inc. (RXRX)?
Recursion Pharmaceuticals, Inc. is a biotechnology company that integrates experimental biology with artificial intelligence and machine learning to accelerate drug discovery and development. The company utilizes high-throughput screening and computational analysis to identify potential therapeutic candidates across various disease areas. Recursion Pharmaceuticals combines biological data generation with advanced algorithms to model complex biological processes and predict drug efficacy and safety. Its platform supports the identification of novel drug targets and the repurposing of existing compounds. The company operates within the pharmaceutical research sector, collaborating with partners to advance its pipeline and technology. Recursion Pharmaceuticals aims to enhance the efficiency and effectiveness of drug discovery through innovative technological integration.
Recursion Pharmaceuticals, Inc. Stock Price Today: Live Overview
The price today is shaped by current market movements, with Recursion Pharmaceuticals, Inc. currently priced at $3.32. It has traded within a range of $3.19 to $3.25 today, reflecting a daily change of -2.7273%.
FAQ: Recursion Pharmaceuticals, Inc. (RXRX)
What is the current price of RXRX stock?
The last traded price is $3.32.
Does RXRX pay dividends?
The company does not pay dividends.
Does RXRX have a formal corporate presence or regional headquarters in the UAE?
Recursion Pharmaceuticals, Inc. operates via partners and distributors in the UAE without an official regional office or subsidiary.
What is RXRX best known for?
The company is most famous for its use of artificial intelligence in drug discovery.
What assets are typically shown together with RXRX?
Commonly shown alongside RXRX: Invesco S&P 500 Equal Weight Energy ETF, Evotec SE, Amgen
Latest shares articles



